
Weight-loss drugs such as Ozempic and Wegovy could boost health in numerous other ways, new research suggests, such as lowering the risk of stroke and dementia.
Researchers used US Department of Veterans Affairs data to find people with diabetes who used drugs containing GLP-1 receptor agonists (GLP-1RA) - which are in appetite suppressant injections - and compared them to people who took other standard diabetes medications to see what impact the newer class of treatments had on 175 other illnesses and health conditions.